Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huanjingjian decoction in Premature Ovarian Insufficiency
NCT07020429Not yet recruiting
- Sponsor
- Shanghai Pulmonary Hospital
- Start
- Sep 2025
- Primary completion
- Jul 2030
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
Randomised, double-blind trial of huanjingjian decoction in premature ovarian insufficiency (POI) (2 arms), sponsored by Shanghai Pulmonary Hospital. Primary endpoint: Disease-Specific Quality of Life Assessment at 6 months. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
huanjingjian decoction
03
Conditions
premature ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT07020429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07020429.